Cindy Tysinger Joins the RBC Board of Directors

IRVING, Texas , Aug. 1, 2012 /PRNewswire/ -- RBC Life Sciences, Inc. (OTCQB: RBCL), is pleased to announce that Cindy L. Tysinger has been appointed as a member of the Company's Board of Directors effective July 24, 2012.  Ms. Tysinger is Chief Executive Officer and founder of GSAT, Inc. (GSATi), which is a provider of business and technology services to global clients. Ms. Tysinger founded GSATi in 2008.

Ms. Tysinger's early career involved the management of information systems and internet technologies for various companies that provided services under contract to the U.S. military and various federal agencies.  In 1996, she began a 12-year association with a multinational direct sales company engaged in the distribution of nutritional products. Ms. Tysinger began this association as an independent distributor where she built and operated a successful distributorship for four years.  Following her success as an independent distributor, and because of her extensive background in information technology, she then joined the company as Chief Information Officer and Senior Vice President of Information Technology.  Ms. Tysinger served in this role for eight years during a time of significant domestic sales growth and rapid international expansion.

Ms. Tysinger was appointed to fill an open seat on the Company's Board of Directors. Her initial term extends until the Company's annual meeting of shareholders in 2014.

"We look forward to the expert advice and counsel that Ms. Tysinger will provide to RBC. Her background in information technology coupled with her experience as an independent distributor make her uniquely suited to contribute significantly to the development and implementation of technology applications that are critical to the success of our business," stated Steve Brown, President of RBC Life Sciences.

About RBC Life Sciences

Through wholly owned subsidiaries, RBC Life Sciences develops, markets and distributes high-quality nutritional supplements and personal care products under its RBC Life brand to a growing population of consumers seeking wellness and a healthy lifestyle. Through its wholly owned subsidiary, MPM Medical, the Company also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the company's website at www.rbclifesciences.com.

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

SOURCE RBC Life Sciences, Inc.